🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Did you know: 2025 marks the 50th(!!!) year of Ophthalmology Times? We're looking back on what's changed in that time. At the American Glaucoma Society meeting, we heard from John Berdahl, MD; Inder Paul Singh, MD; and Shan Lin, MD on just how much has changed: ophthalmologytimes.com/view/50-years-…

#BREAKING: The U.S. FDA granted approval for an expanded indication of eculizumab (Soliris; Alexion/AstraZeneca) to include adult and pediatric patients 6 years of age with generalized myasthenia gravis who are AChR antibody positive. With the approval, it becomes the

ENORMOUS news for the ophthalmology world:

There were ~several~ clinical care guidelines that were updated in 2024, shaping the way physicians diagnose and treat. The NeurologyLive® team put together a wonderful overview of all of those changes, in a single resource: neurologylive.com/view/blueprint…

CE Objectives: Recognize complexity of #fall situations/risk factors & apply to obtaining information from Pw #MS about their individual fall anamnesis. Incorporate evidence-based strategies to strengthen patients' awareness & self-management of fall risk. doi.org/10.7224/1537-2…

In celebration of Ophthalmology Times 50th anniversary, we asked leading experts in the field what they see as the biggest innovation in ophthalmology in the last 5 decades. hubs.li/Q03fX7BG0

Taking over @NeurologyLive today from #AAN2025 in sunny San Diego! ☀️ I’m Dr. Agne MS Neurologist Multiple Sclerosis Neurologist dr Agne Straukiene from @BeeWellWithMS podcast 🧠 All day I’ll be serving up bold science, lived experience & MS breakthroughs—with a twist 💫 Let’s shake up neurology! 🔗

If you missed it earlier today—we've got a second measles death in Texas. See below for more from Contagion:

Episode 3 of CGTLive®'s #ImmunoLogic podcast with Joseph Fraietta, PhD, and Janna Minehart, MD, is now live! Our guest is Dr Marcela Maus, MD, PhD, of MassGeneral News to talk about her research into the use of #CART therapy to treat #glioblastoma. cgtlive.com/view/immunolog…

Learn more about #measles in this general explainer article from Contagion Measles: An Old Foe Has Returned contagionlive.com/view/measles-a… via @contagionlive

#BREAKING: The U.S. FDA approved a new pre-filled syringe administration route for efgartigimod a marketed medication for generalized myasthenia gravis and chronic inflammatory demyelinating polyneuropathy. argenx hubs.li/Q03gWf8W0

The U.S. FDA has expanded the MenQuadfi vaccine's indication for invasive meningococcal disease caused by serogroups A, C, W, and Y that can be used for individuals 6 weeks of age and older—without an upper age limit. Read more from Contagion: contagionlive.com/view/fda-appro…

📘💙The IJMSC has published the full abstracts for the 39th Annual Meeting of the CMSC, taking place May 28–31, 2025, in Phoenix, AZ. 🌵☀️ Explore the latest in #MS research and clinical care: hubs.li/Q03pk6qq0 #MSCare #CMSC25 #Neurology #MultipleSclerosis

We're here! Hope to see you tonight at our art reception in honor of our peer reviewers and our partnership with MS Assoc. of America and their Art Showcase! 5-6pm in room 229B. mymsaa.org/artshowcase

This morning we had the pleasure of speaking with Mary Rensel, MD, of Cleveland Clinic, on her presentation titled "The Interdisciplinary Approach to Wellness in MS" at the #CMSC25! Stay tuned! 🧠☀️ CMSC

An energizing lunch hour at #MADID2025! More interviews, more perspectives, and more insights into infectious diseases, antimicrobial stewardship, and clinical practice. Stay tuned for highlights from today’s conversations and studies. MAD-ID The Antimicrobial Stewardship Meeting®️ contagionlive.com/conference/mad…

Thank you to everyone who came out last night to the Giants of MS recognition ceremony at #CMSC25! Congrats again to this year's inductees! 🎉🏆 CMSC

🎥 At #MADID2025, Dr. Kimberly Leuthner, PharmD FIDSA, from UMC, presented data showing no significant difference in outcomes between TMP/SMX and minocycline for Stenotrophomonas maltophilia pneumonia. MAD-ID The Antimicrobial Stewardship Meeting®️ Listen here: contagionlive.com/view/trimethop…

Day 2 at #ASMicrobe2025 and look who we ran into! 👋 Always a good day when you catch up with friends on the road. Our podcast host, Dr. Rodney E. Rohde, PhD "Doc R", and Dr. Jose Alexander. Stay tuned for more updates from the floor! ASM

🚨New Content! We just launched our latest roundtable discussion on updates in #ALS research and therapeutics with clinical experts in the field in partnership with The ALS Association. Check our the first episode now, with more coming soon! 👉 Watch Now: hubs.li/Q03s-MXS0